Replies to post #159 on Enumeral Biomedical Holdings Inc fka ENUMQ

[Rkmatters]

AACR headings and abstract titles:

Apr 18
Monday, 1:00 PM - 5:00 PM
Poster Session

Adoptive Cell Therapy, Immune Checkpoints, and Vaccines
Section 21

2224: Discovery, development and characterization of a new class of therapeutic anti-PD-1 antibody
Monday, Apr 18, 2016, 1:00 PM - 5:00 PM
Lei Wang, Najmia Amirina, Fellix Scheuplein, Vikki Spaulding, Yanyan Wang, Sri Vadde, M. Isabel Chiu, Daniel Doty, Thomas McQuade, Bin Feng, Sheila Ranganath, Anhco “Cokey” Nguyen. Enumeral Biomedical, Cambridge, MA

Apr 20
Wednesday, 8:00 AM - 12:00 PM
Poster Session

Immune Modulating Agents 2
Section 22

4871: Two novel anti-PD-1 antibodies, 244C8 and 388D4, elicit in vivo antitumor efficacy in a lung PDX tumorgraft in immuno-humanized NSG mice
Wednesday, Apr 20, 2016, 8:00 AM -12:00 PM
Felix Scheuplein, Sheila Ranganath, Bin Feng, Thomas McQuade, Lei Wang, Vikki Spaulding, Sri Vadde, Shanu Mehta, Maria Isabel Chiu, Cokey Nguyen. Enumeral Biomedical Corporation, Cambridge, MA